These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


262 related items for PubMed ID: 10325255

  • 1. The value of basal serum follicle stimulating hormone, luteinizing hormone and oestradiol concentrations following pituitary down-regulation in predicting ovarian response to stimulation with highly purified follicle stimulating hormone.
    Develioglu OH, Cox B, Toner JP, Oehninger S, Muasher SJ.
    Hum Reprod; 1999 May; 14(5):1168-74. PubMed ID: 10325255
    [Abstract] [Full Text] [Related]

  • 2. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG, Erb K, Laursen S, Rasmussen PE, Rex S.
    Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
    [Abstract] [Full Text] [Related]

  • 3. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R, Buckler HM, Matson P, Lieberman B, Burger HG, Hilton B, Horne G, Dyson M, Robertson WR.
    Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
    [Abstract] [Full Text] [Related]

  • 4. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
    Ho JY, Guu HF, Yi YC, Chen MJ, Ho ES.
    Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
    [Abstract] [Full Text] [Related]

  • 5. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K, Bustion S, Loumaye E, Fauser BC.
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [Abstract] [Full Text] [Related]

  • 6. Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone.
    Cabrera RA, Stadtmauer L, Mayer JF, Gibbons WE, Oehninger S.
    Fertil Steril; 2005 Jan; 83(1):42-8. PubMed ID: 15652885
    [Abstract] [Full Text] [Related]

  • 7. Relative influence of serum follicle stimulating hormone, age and other factors on ovarian response to gonadotrophin stimulation.
    Cahill DJ, Prosser CJ, Wardle PG, Ford WC, Hull MG.
    Br J Obstet Gynaecol; 1994 Nov; 101(11):999-1002. PubMed ID: 7999732
    [Abstract] [Full Text] [Related]

  • 8. Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women undergoing ovarian stimulation after pituitary suppression for in vitro fertilization: implications for implantation potential.
    Balasch J, Fábregues F, Creus M, Peñarrubia J, Vidal E, Carmona F, Puerto B, Vanrell JA.
    J Assist Reprod Genet; 2000 Jan; 17(1):20-7. PubMed ID: 10754779
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Influence of serum follicle stimulating hormone to luteinizing hormone ratio during buserelin acetate-induced pituitary desensitization on ovarian response to exogenous gonadotrophins in an in-vitro fertilization and embryo transfer programme.
    Yamashita T, Ishimaru T, Fujishita A, Kawano M, Yamabe T.
    Hum Reprod; 1996 Aug; 11(8):1615-9. PubMed ID: 8921103
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.